How Hadrian, Machina Labs, Divergent-style advanced manufacturing startups raise capital in 2026 with CHIPS, IRA, DPA Title III.
Advanced manufacturing became a top-3 dual-use investment category once the CHIPS Act, IRA, DPA Title III, and DoD Office of Strategic Capital converted reshoring from a talking point into a funded program. Hadrian, Machina Labs, Divergent, Vention, Bright Machines, and Instrumental defined the new archetype: software-native factories serving defense, space, and critical-infrastructure OEMs. Capital pools now blend venture equity, DPA/OSC non-dilutive, and asset-backed project finance.
CHIPS Act awards ($52B) are flowing to TSMC Arizona, Intel Ohio, Micron NY, Samsung Texas, and a growing tier of specialty suppliers. DPA Title III committed $1B+ to critical-mineral and munitions supply chains. The DoD Office of Strategic Capital opened a $984M loan/guarantee program in late 2024 explicitly for dual-use manufacturing. Anduril's Arsenal-1, SpaceX Starbase, and hyperscaler power-equipment demand created a durable OEM pull for domestic advanced manufacturing.
Seed: $5-20M for pilot factory or software platform. Series A: $30-100M for first production line with a signed OEM program. Series B: $100-350M for scale-out — Hadrian ($260M B), Machina Labs ($47M B), Divergent ($230M+ cumulative), and Vention are current reference points. Series C+: $250M-$1B blending equity, DPA/OSC debt, and project finance on individual factories.
Selling generic factory software instead of owning a specific vertical (aerospace machined parts, defense electronics, EV powertrain, semiconductor tooling). Underestimating OEM qualification time (AS9100/Nadcap typically 12-24 months). Treating CHIPS/DPA/OSC as optional — competitors with the non-dilutive stack win on price and dilution. Raising pure venture equity for capex that project finance would cover.
Investor directory · Fundraising library · Articles A–Z · Company funding database